Personalized interventions for older adults with mild behavioral impairment
Construction and Empirical Study of Personalized Intervention Based on Health Portrait in Mild Behavioral Impairment
NA · Fujian Provincial Hospital · NCT06416514
This study is testing personalized non-drug treatments for older adults with mild behavioral issues to see if they can improve symptoms and help delay dementia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Fujian Provincial Hospital (other) |
| Locations | 1 site (Fuzhou, Fujian) |
| Trial ID | NCT06416514 on ClinicalTrials.gov |
What this trial studies
This study focuses on older adults diagnosed with mild behavioral impairment (MBI) to explore personalized interventions aimed at improving neuropsychiatric symptoms and delaying the progression to dementia. Utilizing the Landmark model, the research will assess various influencing factors on MBI and dementia progression through dynamic risk prediction. The goal is to develop tailored non-drug interventions that address the unique needs of each patient, thereby enhancing their quality of life and promoting healthy aging.
Who should consider this trial
Good fit: Ideal candidates for this study are older adults aged 60 and above who meet the diagnostic criteria for mild behavioral impairment and can communicate effectively.
Not a fit: Patients with severe physical diseases or other neurological conditions that impair cognitive function may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of dementia and improve the overall well-being of older adults with mild behavioral impairment.
How similar studies have performed: While there have been numerous studies on dementia risk factors, this specific approach of personalized interventions for MBI is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meet the ISTAART diagnostic criteria for MBI; * Age ≥60 years old; * No obvious visual or hearing impairment; * Have the ability of language communication, can complete the scale assessment. Exclusion Criteria: * Patients with severe physical diseases and unable to complete cognitive function screening; * Patients with other neurological diseases and serious medical diseases that can cause brain dysfunction.
Where this trial is running
Fuzhou, Fujian
- Fujian Provincial Hospital — Fuzhou, Fujian, China (RECRUITING)
Study contacts
- Study coordinator: Shi Yanhong
- Email: Cordelia88@163.com
- Phone: 89-15150947040
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neurocognitive Disorders, Mild behavioral impairment, Older adults, Personalized intervention, Health portrait, Neuropsychiatric symptoms